Accretive Health, Inc.  

(Public, NYSE:AH)   Watch this stock  
11.08
+0.21 (1.93%)
May 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 10.90 - 11.18
52 week 8.55 - 14.19
Open 10.90
Vol / Avg. 260,786.00/460,922.00
Mkt cap 1.08B
P/E 66.91
Div/yield     -
EPS 0.17
Shares 97.27M
Beta     -
Inst. own 63%
May 27, 2013
Q4 2012 Accretive Health, Inc. Earnings Release Add to calendar
Apr 2, 2013
Accretive Health, Inc. to Discuss Appointment of Stephen Schuckenbrock as President and CEO - Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin 1.23% 3.53%
Operating margin 2.87% 5.82%
EBITD margin - 6.82%
Return on average assets 2.60% 9.31%
Return on average equity 4.26% 15.32%
Employees 2,700 -
Carbon Disclosure Rating - -

Address

Suite 2700, 401 North Michigan Avenue
CHICAGO, IL 60611
United States - Map
+1-313-3247820 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Accretive Health, Inc. (Accretive Health) is a provider of services to the healthcare providers. The Company�s three offerings are revenue cycle management; quality and total cost of care, and physician advisory services. Its integrated revenue cycle management service offering helps the United States healthcare providers to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation and collections. Accretive Health�s customers are multi-hospital systems, including faith-based or community healthcare systems, academic medical centers and independent clinics, and the physician practice groups affiliated with those systems.

Officers and directors

Stephen F. Schuckenbrock President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Etienne H. Deffarges Vice Chairman of the Management Board
Age: 54
Bio & Compensation  - Reuters
John T. Staton Chief Financial Officer, Treasurer
Age: 51
Bio & Compensation  - Reuters
Walter H. Ettinger Jr. Senior Vice President - Quality and Total Cost of Care
Age: 48
Bio & Compensation  - Reuters
Richard E. Gillette Senior Vice President
Age: 49
Bio & Compensation  - Reuters
Gregory N. Kazarian Senior Vice President
Bio & Compensation  - Reuters
Mary A. Tolan Non-Executive Chairman of the Board
Bio & Compensation  - Reuters
J. Michael Cline Director
Age: 52
Bio & Compensation  - Reuters
Steven J. Shulman Director
Age: 61
Bio & Compensation  - Reuters
Edgar M. Bronfman Jr. Independent Director
Age: 75
Bio & Compensation  - Reuters